Literature DB >> 12377300

Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms.

Robert M Carney1, Kenneth E Freedland, Gregory E Miller, Allan S Jaffe.   

Abstract

Depression increases the risk of cardiac mortality and morbidity in patients with coronary heart disease (CHD), but the mechanisms that underlie this association remain unclear. This review considers the evidence for several behavioral and physiological mechanisms that might explain how depression increases the risk for incident coronary disease and for subsequent cardiac morbidity and mortality. The candidate mechanisms include: (1). antidepressant cardiotoxicity; (2). association of depression with cardiac risk factors such as cigarette smoking, hypertension, diabetes, and reduced functional capacity; (3). association of depression with greater coronary disease severity; (4). nonadherence to cardiac prevention and treatment regimens; (5). lower heart rate variability (HRV) reflecting altered cardiac autonomic tone; (6). increased platelet aggregation; and (7). inflammatory processes. Despite recent advances in our understanding of these potential mechanisms, further research is needed to determine how depression increases risk for cardiac morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377300     DOI: 10.1016/s0022-3999(02)00311-2

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  183 in total

1.  Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome.

Authors:  Ian M Kronish; Nina Rieckmann; Daichi Shimbo; Matthew Burg; Karina W Davidson
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

Review 2.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

3.  Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Authors:  Karina W Davidson; Matthew M Burg; Ian M Kronish; Daichi Shimbo; Lucia Dettenborn; Roxana Mehran; David Vorchheimer; Lynn Clemow; Joseph E Schwartz; Francois Lespérance; Nina Rieckmann
Journal:  Arch Gen Psychiatry       Date:  2010-05

4.  [Postoperative multimodal pain management : Cost-minimisation analysis from a hospital's point of view].

Authors:  A Bernschein; M Redaèlli; S Stock
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

5.  Perceptions of cardiac risk among a low-income urban diabetic population.

Authors:  Jerilyn K Allen; Alison Purcell; Sarah Szanton; Cheryl R Dennison
Journal:  J Health Care Poor Underserved       Date:  2010-02

6.  Comparison of actigraphic and subjective measures of sleep in implantable cardioverter defibrillator and coronary artery disease patients.

Authors:  Natalie J Cross; Christina S McCrae; Karen M Smith; Jamie B Conti; Samuel F Sears
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

7.  A new potential marker for abnormal cardiac physiology in depression.

Authors:  Grant L Iverson; Michael B Gaetz; Edward J Rzempoluck; Peter McLean; Wolfgang Linden; Ronald Remick
Journal:  J Behav Med       Date:  2005-10-13

8.  Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study.

Authors:  Shaoyong Su; Andrew H Miller; Harold Snieder; J Douglas Bremner; James Ritchie; Carisa Maisano; Linda Jones; Nancy V Murrah; Jack Goldberg; Viola Vaccarino
Journal:  Psychosom Med       Date:  2008-12-10       Impact factor: 4.312

9.  Association of depressive symptoms, trait anxiety, and perceived stress with subclinical atherosclerosis: results from the Chicago Healthy Aging Study (CHAS).

Authors:  Rosalba Hernandez; Norrina Bai Allen; Kiang Liu; Jeremiah Stamler; Kathryn Jean Reid; Phyllis C Zee; Donghong Wu; Joseph Kang; Daniel B Garside; Martha L Daviglus
Journal:  Prev Med       Date:  2014-01-13       Impact factor: 4.018

10.  Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study.

Authors:  Lawson R Wulsin; Dominique Musselman; Christian Otte; Erica Bruce; Sadia Ali; Mary A Whooley
Journal:  Psychosom Med       Date:  2009-03-17       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.